Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate

• Main Authors: Douglas J. Taylor (Author), Vera Halpern (Author), Vivian Brache (Author), Luis Bahamondes (Author), Jeffrey T. Jensen (Author), Laneta J. Dorflinger (Author)
• Format: Book
• Published: Elsevier, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: To characterize the relationship between serum medroxyprogesterone acetate (MPA) concentrations and ovulation suppression, and to estimate the risk of ovulation for investigational subcutaneous regimens of Depo-Provera CI (Depo-Provera) and Depo-subQ Provera 104 (Depo-subQ). Study Design...